In order to access the Stocks Valuation, please log on to your TD Ameritrade account or open an account!
CBD Global Sciences Inc. is a Canada-based cannabidiol (CBD) producer. The Company is engaged in the business of producing and selling industrial hemp derived CBD infused consumable and topical products, including but not limited to CBD oil tincture drops, CBD hydration beverages, and CBD topicals. It markets and sells its own brand of CBD oil and byproducts under the Aethics and CannaOil brands (Products), which includes CBD Oil tinctures (liquid products), CBD capsules, CBD topicals, hydration products and confectionary products. Its hemp-derived CBD extracts are sold through distributors, brick and mortar retailers and online. The Company, through its wholly owned subsidiaries, Global Sciences Holdings, Resinosa LLC and Legacy Distribution Group, is delivering CBD products both in a retail and e-commerce formats. Its subsidiaries include Strasburg Pharms, LLC, Global NV Corp., CannaOil, Inc., SMBT, LLC, Global Sciences IP, LLC and Energy Unleased LLC, among others.
|
|
|
|
|
In order to access the Stocks Valuation, please log on to your TD Ameritrade account or open an account!
Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.